NCT01565382View on ClinicalTrials.gov

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Alzheimer's Disease
Interventions
DRUG

florbetapir F 18

IV injection, 370MBq (10mCi), single dose (intervention for Study A05 participants, source of scans for this study)

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY